Cargando…

In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a substantial number of deaths around the world, making it a serious and pressing public health hazard. Phytochemicals could thus provide a rich source of potent and safer anti-SARS-CoV-2 drugs. The absence of approved treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Md. Mominur, Islam, Md. Rezaul, Akash, Shopnil, Mim, Sadia Afsana, Rahaman, Md. Saidur, Emran, Talha Bin, Akkol, Esra Küpeli, Sharma, Rohit, Alhumaydhi, Fahad A., Sweilam, Sherouk Hussein, Hossain, Md. Emon, Ray, Tanmay Kumar, Sultana, Sharifa, Ahmed, Muniruddin, Sobarzo-Sánchez, Eduardo, Wilairatana, Polrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441699/
https://www.ncbi.nlm.nih.gov/pubmed/36072227
http://dx.doi.org/10.3389/fcimb.2022.929430
_version_ 1784782640781459456
author Rahman, Md. Mominur
Islam, Md. Rezaul
Akash, Shopnil
Mim, Sadia Afsana
Rahaman, Md. Saidur
Emran, Talha Bin
Akkol, Esra Küpeli
Sharma, Rohit
Alhumaydhi, Fahad A.
Sweilam, Sherouk Hussein
Hossain, Md. Emon
Ray, Tanmay Kumar
Sultana, Sharifa
Ahmed, Muniruddin
Sobarzo-Sánchez, Eduardo
Wilairatana, Polrat
author_facet Rahman, Md. Mominur
Islam, Md. Rezaul
Akash, Shopnil
Mim, Sadia Afsana
Rahaman, Md. Saidur
Emran, Talha Bin
Akkol, Esra Küpeli
Sharma, Rohit
Alhumaydhi, Fahad A.
Sweilam, Sherouk Hussein
Hossain, Md. Emon
Ray, Tanmay Kumar
Sultana, Sharifa
Ahmed, Muniruddin
Sobarzo-Sánchez, Eduardo
Wilairatana, Polrat
author_sort Rahman, Md. Mominur
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a substantial number of deaths around the world, making it a serious and pressing public health hazard. Phytochemicals could thus provide a rich source of potent and safer anti-SARS-CoV-2 drugs. The absence of approved treatments or vaccinations continues to be an issue, forcing the creation of new medicines. Computer-aided drug design has helped to speed up the drug research and development process by decreasing costs and time. Natural compounds like terpenoids, alkaloids, polyphenols, and flavonoid derivatives have a perfect impact against viral replication and facilitate future studies in novel drug discovery. This would be more effective if collaboration took place between governments, researchers, clinicians, and traditional medicine practitioners’ safe and effective therapeutic research. Through a computational approach, this study aims to contribute to the development of effective treatment methods by examining the mechanisms relating to the binding and subsequent inhibition of SARS-CoV-2 ribonucleic acid (RNA)-dependent RNA polymerase (RdRp). The in silico method has also been employed to determine the most effective drug among the mentioned compound and their aquatic, nonaquatic, and pharmacokinetics’ data have been analyzed. The highest binding energy has been reported -11.4 kcal/mol against SARS-CoV-2 main protease (7MBG) in L05. Besides, all the ligands are non-carcinogenic, excluding L04, and have good water solubility and no AMES toxicity. The discovery of preclinical drug candidate molecules and the structural elucidation of pharmacological therapeutic targets have expedited both structure-based and ligand-based drug design. This review article will assist physicians and researchers in realizing the enormous potential of computer-aided drug design in the design and discovery of therapeutic molecules, and hence in the treatment of deadly diseases.
format Online
Article
Text
id pubmed-9441699
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94416992022-09-06 In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective Rahman, Md. Mominur Islam, Md. Rezaul Akash, Shopnil Mim, Sadia Afsana Rahaman, Md. Saidur Emran, Talha Bin Akkol, Esra Küpeli Sharma, Rohit Alhumaydhi, Fahad A. Sweilam, Sherouk Hussein Hossain, Md. Emon Ray, Tanmay Kumar Sultana, Sharifa Ahmed, Muniruddin Sobarzo-Sánchez, Eduardo Wilairatana, Polrat Front Cell Infect Microbiol Cellular and Infection Microbiology The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a substantial number of deaths around the world, making it a serious and pressing public health hazard. Phytochemicals could thus provide a rich source of potent and safer anti-SARS-CoV-2 drugs. The absence of approved treatments or vaccinations continues to be an issue, forcing the creation of new medicines. Computer-aided drug design has helped to speed up the drug research and development process by decreasing costs and time. Natural compounds like terpenoids, alkaloids, polyphenols, and flavonoid derivatives have a perfect impact against viral replication and facilitate future studies in novel drug discovery. This would be more effective if collaboration took place between governments, researchers, clinicians, and traditional medicine practitioners’ safe and effective therapeutic research. Through a computational approach, this study aims to contribute to the development of effective treatment methods by examining the mechanisms relating to the binding and subsequent inhibition of SARS-CoV-2 ribonucleic acid (RNA)-dependent RNA polymerase (RdRp). The in silico method has also been employed to determine the most effective drug among the mentioned compound and their aquatic, nonaquatic, and pharmacokinetics’ data have been analyzed. The highest binding energy has been reported -11.4 kcal/mol against SARS-CoV-2 main protease (7MBG) in L05. Besides, all the ligands are non-carcinogenic, excluding L04, and have good water solubility and no AMES toxicity. The discovery of preclinical drug candidate molecules and the structural elucidation of pharmacological therapeutic targets have expedited both structure-based and ligand-based drug design. This review article will assist physicians and researchers in realizing the enormous potential of computer-aided drug design in the design and discovery of therapeutic molecules, and hence in the treatment of deadly diseases. Frontiers Media S.A. 2022-08-22 /pmc/articles/PMC9441699/ /pubmed/36072227 http://dx.doi.org/10.3389/fcimb.2022.929430 Text en Copyright © 2022 Rahman, Islam, Akash, Mim, Rahaman, Emran, Akkol, Sharma, Alhumaydhi, Sweilam, Hossain, Ray, Sultana, Ahmed, Sobarzo-Sánchez and Wilairatana https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Rahman, Md. Mominur
Islam, Md. Rezaul
Akash, Shopnil
Mim, Sadia Afsana
Rahaman, Md. Saidur
Emran, Talha Bin
Akkol, Esra Küpeli
Sharma, Rohit
Alhumaydhi, Fahad A.
Sweilam, Sherouk Hussein
Hossain, Md. Emon
Ray, Tanmay Kumar
Sultana, Sharifa
Ahmed, Muniruddin
Sobarzo-Sánchez, Eduardo
Wilairatana, Polrat
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
title In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
title_full In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
title_fullStr In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
title_full_unstemmed In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
title_short In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
title_sort in silico investigation and potential therapeutic approaches of natural products for covid-19: computer-aided drug design perspective
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441699/
https://www.ncbi.nlm.nih.gov/pubmed/36072227
http://dx.doi.org/10.3389/fcimb.2022.929430
work_keys_str_mv AT rahmanmdmominur insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT islammdrezaul insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT akashshopnil insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT mimsadiaafsana insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT rahamanmdsaidur insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT emrantalhabin insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT akkolesrakupeli insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT sharmarohit insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT alhumaydhifahada insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT sweilamsheroukhussein insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT hossainmdemon insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT raytanmaykumar insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT sultanasharifa insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT ahmedmuniruddin insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT sobarzosanchezeduardo insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective
AT wilairatanapolrat insilicoinvestigationandpotentialtherapeuticapproachesofnaturalproductsforcovid19computeraideddrugdesignperspective